Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

Biotechnology

Healthcare
$4.16 +2.94%

+$0.14 today

Market cap
$120.02M
Beta
0.29
P/E (TTM)
-3.0
EPS (TTM)
-$1.66
52W Low $3.20High $12.99

Volume 0.27M

Average 0.08M

NTHI Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Neonc Technologies Holdings, Inc.NASDAQ: NTHI

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents falls 97.5% from a year ago

Cash & equivalents stood at $138.6K at the end of Q1 FY2026, down 97.5% from a year earlier and up 136.0% from the prior quarter.

Context

  • Cash & equivalents amounted to 4.2% of total assets at the end of Q1 FY2026, down 60.3 pp from a year earlier.

What to watch

Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -97.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$138.6K+136.0% QoQ
Last fiscal yearDec 2025
$58.73K— YoY
Year agoMar 2025
$5.44M-97.5% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-97.5%——
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
58.73K USD
Year-over-year change
—

Cash & Equivalents vs competitors

How NTHI compares with its peers on the latest reported figures

No competitor Cash & Equivalents figures are available to compare.

Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

Intrinsic Alpha fair value

Locked

Current Price

$4.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.